scispace - formally typeset
H

Hai Yu

Researcher at University of California, Davis

Publications -  252
Citations -  9928

Hai Yu is an academic researcher from University of California, Davis. The author has contributed to research in topics: Sialic acid & Glycan. The author has an hindex of 52, co-authored 252 publications receiving 8571 citations. Previous affiliations of Hai Yu include Northwest A&F University & University of Leeds.

Papers
More filters
Journal ArticleDOI

Cluster randomization trial of sequence mass screening for colorectal cancer.

TL;DR: Mass screening with a reverse passive hemagglutination fecal occult blood test along with an individual attributive degree value score was effective in reducing mortality from rectal cancer but not in reduced mortality from colon cancer or the incidence of colorectal cancer.
Proceedings ArticleDOI

Extremum-seeking control strategy for ABS system with time delay

TL;DR: In this article, an improved extremum-seeking control is developed via sliding mode to apply to systems with time delay and to avoid the problem of excessive oscillation, which is applied to a pneumatic anti-lock brake system (ABS) example to achieve better braking performance.
Journal ArticleDOI

Oral Streptococci Utilize a Siglec-Like Domain of Serine-Rich Repeat Adhesins to Preferentially Target Platelet Sialoglycans in Human Blood

TL;DR: The data indicate that circulating platelets may act as inadvertent Trojan horse carriers of oral streptococci to the site of damaged endocardium, and provide an explanation why it is that certain viridans group strePTococci have a selective advantage in colonizing damaged cardiac valves and cause infective endocarditis.
Journal ArticleDOI

Enzymatic synthesis of fluorinated mechanistic probes for sialidases and sialyltransferases

TL;DR: 3-Fluoro-sialosides have been enzymatically synthesized and could be used as potential inhibitors and mechanistic probes for sialidases and as probes forSialic acid-binding proteins.
Journal ArticleDOI

Tumor cell membrane-bound heat shock protein 70 elicits antitumor immunity.

TL;DR: Findings indicate that the tumor cell membrane-bound HSP70 can be used as cancer vaccine to elicit protective antitumor immunity.